Form 4: SeaStar Medical Director Boosts Share Holdings

SeaStar Medical Holding Corp. director Jennifer A. Baird acquired 4,200 shares of common stock at $0.2351 per share.

Summary

• Jennifer A. Baird, a Director of SeaStar Medical Holding Corp. (ICU), acquired 4,200 shares of the company's common stock.
• The transaction occurred on December 19, 2025, at a price of $0.2351 per share.
• Following this acquisition, Jennifer A. Baird directly beneficially owns 36,200 shares of SeaStar Medical Holding Corp. common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Eric Schlorff, the Chief Executive Officer of SeaStar Medical Holding Corporation, is appointed as attorney-in-fact for Jennifer A. Baird to execute and file Forms 3, 4, and 5.

Sentiment

Score: 7

Explanation: A director's purchase of company stock typically signals confidence in the company's future prospects and valuation, which is generally viewed positively by the market.

Positives

• A director's purchase of company stock (4,200 shares at $0.2351) signals confidence in the company's future prospects and valuation.

Related Party Transactions

• Jennifer A. Baird, a Director of SeaStar Medical Holding Corp., acquired 4,200 shares of the company's common stock, which constitutes an insider transaction.

Stakeholder Impact

• Shareholders may interpret the director's purchase as a positive signal of management's confidence in the company's future performance and stock value.

Key Dates

Recommendation

While a director's purchase of shares is a positive signal of confidence, this specific transaction involves a relatively small number of shares (4,200) compared to the company's overall market capitalization. A seasoned investor would likely view this as a favorable indicator but would require further fundamental analysis of the company's financial health, strategic direction, and broader market conditions before making a 'buy' or 'strong buy' recommendation. Therefore, a 'hold' recommendation is appropriate, acknowledging the positive insider sentiment without overstating its immediate impact on investment strategy.

Keywords

SeaStar Medical Holding Corp, ICU, Jennifer A. Baird, Insider Trading, Stock Purchase, Director Share Acquisition, Form 4, SEC Filing, Rule 10b5-1(c)